title: Changes in protein expression in p53 deleted spontaneous thymic lymphomas.
abstract: By the use of high-resolution two-dimensional gel electrophoresis and computerized image analysis we investigated and compared the expression of cellular proteins from p53 positive (+/+) mouse thymocytes, p53-/- thymocytes before neoplastic transformation, and from cell lines derived from two spontaneous p53-/- thymic lymphomas, SM5 and SM7. A total of around 1500 proteins were detected on individual gels. Only changes in protein expression by a factor of 2 or more were considered. In the thymic lymphoma cells 3-5% of the proteins were found to be differentially regulated when compared with the protein expression in p53+/+ and p53-/- thymocytes. Only a minority (13 proteins) of the quantitatively changed proteins were common for the two thymic lymphoma cell lines, suggesting that the p53 deficiency mainly results in genetic dysfunctions which are individual for a given tumor. Two of the detected proteins increased their expression levels by more than 10 times from the p53+/+ to the p53-/- thymocytes and these high expression levels were also found in thymic lymphomas. The two proteins were identified by mass spectrometry as acidic ribosomal phosphoprotein P0 and a 33-kDa protein with a primary structure containing motifs of the glyoxalase-bleomycin resistance protein family (MDR) as deduced from the cDNA.
authors.affiliation: Department of Medical Biochemistry, University of Aarhus, DK-8000 Aarhus C, Denmark. bh@biokemi.au.dk
authors.forename: Bent
authors.initials: B
authors.lastname: Honoré
authors.forename: Henrik
authors.initials: H
authors.lastname: Vorum
authors.forename: Anders Elm
authors.initials: AE
authors.lastname: Pedersen
authors.forename: Søren
authors.initials: S
authors.lastname: Buus
authors.forename: Mogens H
authors.initials: MH
authors.lastname: Claësson
mesh_terms: D000818:Animals; D001761:Bleomycin / Q000633:toxicity; D045744:Cell Line, Tumor; D018432:Drug Resistance, Multiple; D005434:Flow Cytometry; D017353:Gene Deletion; D015972:Gene Expression Regulation, Neoplastic / Q000235:genetics*; D016158:Genes, p53 / Q000235:genetics*; D005819:Genetic Markers; D051379:Mice; D018345:Mice, Knockout; D009363:Neoplasm Proteins / Q000235:genetics / Q000378:metabolism; D010750:Phosphoproteins / Q000378:metabolism; D012269:Ribosomal Proteins / Q000378:metabolism; D013601:T-Lymphocytes / Q000502:physiology; D013945:Thymoma / Q000235:genetics*; D013953:Thymus Neoplasms / Q000235:genetics*; D016159:Tumor Suppressor Protein p53 / Q000172:deficiency* / Q000235:genetics*
chemical_list: D005819:Genetic Markers; D009363:Neoplasm Proteins; D010750:Phosphoproteins; D012269:Ribosomal Proteins; D016159:Tumor Suppressor Protein p53; D001761:Bleomycin